Table 1. Comparison of patients characteristics between the studied groups: group-30W, group-40W and group-50W; BMI - body mass index, BSA - body surface area. Table 1. Comparison of patients characteristics between the studied groups: group-30W, group-40W and group-50W; BMI - body mass index, BSA - body surface area. Table 1. Comparison of patients characteristics between the studied groups: group-30W, group-40W and group-50W; BMI - body mass index, BSA - body surface area. Table 1. Comparison of patients characteristics between the studied groups: group-30W, group-40W and group-50W; BMI - body mass index, BSA - body surface area. Table 1. Comparison of patients characteristics between the studied groups: group-30W, group-40W and group-50W; BMI - body mass index, BSA - body surface area.
Patients, n=30 1 (n=10) 2 (n=10) 3 (n=10) ANOVA
group-30W group-40W group-50W p
Age [years], mean (SD) 62(10) 61(8) 61(7) 0.72
BMI [kg/m2], mean (SD) 29(4) 29(3) 29(5) 0.95
BSA [m2], mean (SD) 2(0) 2(0) 2(0) 0.87
Sex - Male, in numbers (%) 6 7 6 0.87
Paroxysmal atrial fibrillation, in numbers (%) 5 5 6 0.99
Persistent atrial fibrillation, in numbers (%) 5 5 5 0.99
CHA2DS2-VASc score, median (25-75%) 2(0-2) 2(0-2) 1(0-3) 0.96
Left atrium size [mm], mean (SD) 43(5.5) 42(2.2) 43(4.6) 0.97
Left Ventricular Ejection Fracion [%], mean (SD) 59(2) 61(4) 60(3) 0.84
Left atrial appendage Vmax [cm/s], mean (SD) 58(21) 58(25) 57(27) 0.99